Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Restructuring Costs (2024 - 2025)

Historic Restructuring Costs for Editas Medicine (EDIT) over the last 2 years, with Q2 2025 value amounting to $26.1 million.

  • Editas Medicine's Restructuring Costs changed N/A to $26.1 million in Q2 2025 from the same period last year, while for Sep 2025 it was $79.2 million, marking a year-over-year change of. This contributed to the annual value of $12.2 million for FY2024, which is N/A changed from last year.
  • Per Editas Medicine's latest filing, its Restructuring Costs stood at $26.1 million for Q2 2025.
  • In the past 5 years, Editas Medicine's Restructuring Costs ranged from a high of $40.9 million in Q1 2025 and a low of $12.2 million during Q4 2024